CD8A and neoplasm: In both the A20.IIA-GFP and BAL17CNS lymphoma models, CD4+ and CD8+ T cells, reactive B cells, and increased numbers of CD11b+ and CD11c+ cells intermingle with tumor cells (Figure 6a).